From PCOS to PMOS: Implications for Women’s Health

Polycystic Ovary Syndrome (PCOS) has been officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS). This change emphasizes that the condition is a complex hormonal and metabolic disorder affecting the whole body, rather than just a gynecological issue. Additionally, it clarifies that the "cysts" associated with this condition are not true ovarian cysts but rather multiple small, underdeveloped egg follicles that stall in the ovaries, preventing regular ovulation.

Although the name has changed, the symptoms associated with the condition, such as irregular periods and fertility issues, weight gain, excess facial or body hair, and acne, as well as the medical criteria used for diagnosis, remain the same. By using this updated terminology, healthcare providers can ensure that patients receive comprehensive care addressing the underlying metabolic issues related to the condition.

When it comes to fertility care for patients with PMOS, treatment remains the same. The goal continues to be the regulation of menstrual cycles, the induction of ovulation, or, if necessary, the use of in vitro fertilization (IVF) to achieve pregnancy.